The DNAs of a varicella-zoster virus vaccine and its parental virus were compared by CsCl buoyant density centrifugation and restriction enzyme cleavage analysis. The varicella-zoster virus vaccine DNA showed a heterogeneous buoyant profile and altered restriction enzyme cleavage patterns. These changed properties are probably the result of the accumulation of virus containing defective varicellazoster virus DNA during extensive cell culture passage of the vaccine virus.
The DNAs of a varicella-zoster virus vaccine and its parental virus were compared by CsCl buoyant density centrifugation and restriction enzyme cleavage analysis. The varicella-zoster virus vaccine DNA showed a heterogeneous buoyant profile and altered restriction enzyme cleavage patterns. These changed properties are probably the result of the accumulation of virus containing defective varicellazoster virus DNA during extensive cell culture passage of the vaccine virus.
Varicella-zoster virus (VZV) infection of humans causes an acute illness (varicella or chicken pox), occurs almost always in childhood, and is followed by a life-long, usually inapparent infection. For normal children, varicella is an annoying but not a dangerous disease (18) . In sharp contrast, varicella in an immunocompromised child is a serious, often fatal, disease (7, 11) . In response to the seriousness of varicella in immunocompromised children, Takahashi and his collaborators (24) have developed a live, attenuated VZV vaccine, which is now undergoing limited clinical trials. As the DNA of the VZV vaccine is uncharacterized, we undertook a sideby-side comparison of the vaccine VZV DNA with the parental VZV DNA.
VZV Figure 1A shows the results of one such experiment for VZV (parOka) DNA at in vitro passage 11 Fig. 1A ). VZV DNA at lighter densities gave rise to altered Hindm cleavage pattems (Fig. 1B, lanes 5 to 8) . In particular, three DNA bands of sizes between 3 and 5 kilobase pairs were very prominent (Fig.  1B, lanes 6 to 8) . The HinduII cleavage pattem of the total passage 22 VZV (parOka) DNA is shown in Fig. 1B (Fig. 1B, lane 10) . After the effect of in vitro passage on cleavage pattern had been examined for VZV (parOka) DNA, we turned our attention to VZV (vacOka) DNA, which had been passed at least 24 times in culture before becoming the vaccine. Passage numbers for VZV (vacOka) indicate passage in our laboratory. The combined CsCl buoyant density-HindIII cleavage experiment was carried out for passage 8 (in our laboratory, but at least passage 32 overall) VZV (vacOka) DNA. The results of one representative experiment are shown in Fig. 1C . VZV (vacOka) DNA yielded a very disperse buoyant density profile in a CsCl gradient, even more disperse than that of passage 22 VZV (parOka) DNA (cf. Fig. 1B and C) . A substantial portion of the VZV (vacOka) DNA banded at densities less than 1.705 g/cm3 (Fig.   1C, lanes 6 to 9) . The Hindm cleavage pattem of VZV (vacOka) DNA of buoyant density 1.705 g/cm3 (Fig. 1C, lanes 2 to 4) was indistinguishable from the patterns of passage 11 and 22 VZV (parOka) DNA of the same density (cf. (Fig. 1C, lanes 5 to 7) showed three prominent bands between 3 and 5 kilobase pairs, as seen for passage 22 VZV (parOka) DNA (Fig. 1B, lanes 6 to 8) . The HindIII cleavage pattem of VZV (vacOka) DNA of a density significantly lighter than 1.705 g/ cm3 (Fig. 1C, lanes 7 to 9) yielded many additional DNA bands. The HindIII cleavage pattem of total VZV (vacOka) DNA (Fig. 1C, lane  10) was simnilar to the pattem of total passage 22 VZV (parOka) DNA (Fig. 1B, lane 9 ). These experimnents, using two different lots of the VZV vaccine as the starting material for virus growth and DNA preparation, produced analogous results (data not shown). With both lots ofvaccine, there were small changes in the total VZV (vacOka) DNA cleavage pattem at each in vitro passage (data not shown).
The restriction endonuclease cleavage patterns ofVZV (parOka) and VZV (vacOka) DNAs of the CsCl buoyant density 1.705 g/cm3 were compared, using six restriction enzymes (Fig. 2 (Fig. 2, lane 2) and VZV (vacOka) DNA (Fig. 2, lane 3) revealed a number of differences in the cleavage patterns (arrows in Fig. 2 ). These differences encompass both the size and the number of bands. Digestion by KpnI revealed that VZV (vacOka) DNA (Fig. 2, lane  15 ) gave rise to one additional band when compared with VZV (parOka) DNA (Fig. 2, lane 14) . SmaI cleavage also revealed a difference in the size of one VZV (vacOka) DNA band compared with VZV (parOka) DNA (data not shown). Cleavage of VZV (vacOka) and (parOka) DNAs of density 1.705 g/cm3 by BglII, EcoRI, and HindIII did not distinguish between the two (Fig. 2, lanes 5 and 6, 8 and 9 , and 11 and 12, respectively).
VZV cannot be plaque-purified by current techniques. In addition, stable, truly cell-free VZV cannot be easily obtained, if at all (25) . Therefore, we propagated VZV (parOka) by mixing VZV-infected cells with uninfected cells. As a consequence, there was little control of the multiplicity of infection. The effects on virus DNA after serial, undiluted passage of the virus have been studied for several herpesviruses (2) (3) (4) 8, 10, 15, 22, 26) . The result ofhigh-multiplicity passage is the synthesis of defective herpesvirus DNA. Defective herpesvirus DNA can have a different buoyant density than wild-type DNA or a changed restriction enzyme cleavage pattern or both. The observed changes in the buoyant density and HindIH cleavage pattern of VZV (parOka) DNA after 20 or more passages in culture (Fig. 1A and B) most probably reflect the accumulation of defective VZV DNA. The heterogeneous buoyant density and altered restriction enzyme cleavage patterns ( Fig. 1C and  2 ) of VZV (vacOka) DNA strongly suggest that VZV (vacOka) DNA is a population of molecules composed largely of defective VZV DNA. The DNAs corresponding to density 1.705g/cm3 were selected and digested by the specified restriction endonucleases. The resulting VZV DNA fragments were separated by agarose gel electrophoresis (19) . The gels were dried, and fluorography was performed (5, 6) . Lane 1 contained EcoRI-cleaved A DNA. Lanes 2 and 3 contained HpaI-cleaved VZV (parOka) and (vacOka) DNAs, respectively. Lanes 4, 5, and 6 contained BglIcleaved A, VZV (parOka), and VZV (vacOka) DNAs, respectively. Lanes 7, 8 , and 9 contained EcoRI-cleaved A, VZV (parOka), and VZV (vacOka) DNAs, respectively. Lanes 10, 11, and 12 contained HindIII-cleaved A, VZV (parOka), and VZV (vacOka) DNAs, respectively. Lane 13 contained EcoRI-cleaved A DNA. Lanes 14 and 15 contained KpnI-cleaved VZV (parOka) and (vacOka) DNAs, respectively. Arrows point to differences between the VZV (parOka) and VZV (vacOka) DNAs. Asterisks mark regions of suspected differences. VZV (vacOka) DNA population contained DNA of more "defectiveness" than passage 22 VZV (parOka) DNA (Fig. 1B and C) . This observation may be related to two facts: (i) VZV (vacOka) has been passed in vitro more times (at least 32 passages) than VZV (parOka); and (ii) VZV (vacOka) has been passed in guinea pig embryo cells between passages in human cells (24) , whereas VZV (parOka) has been passed only in human cells.
VZV (vacOka) DNA of buoyant density 1.705 g/cm3 was isolated from a CsCl gradient and compared by restriction enzyme cleavage to VZV (parOka) DNA of the same density. Six restriction enzyme cleavage patterns were examined (Fig. 2) 
